Olufunmilayo I Olopade

发表

A meta‐analysis approach with filtering for identifying gene‐level gene–environment interactions

Jiebiao Wang, Lin S Chen, Dezheng Huo, 2018, Genetic epidemiology.

Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.

David Wholley, Anne Wallace, Michael Hogarth, 2012, Journal of Clinical Oncology.

Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers.

Li Lan, Andrew R. Jamieson, Hui Li, 2014, Medical physics.

Fourier component imaging of water resonance in the human breast provides markers for malignancy

Xiaobing Fan, Akiko Shimauchi, Gregory S Karczmar, 2009, Physics in medicine and biology.

Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer

Dezheng Huo, Olufunmilayo I Olopade, O. Olopade, 2013, SpringerPlus.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

Zhiyuan Hu, Nicholas P Gauthier, Charles M Perou, 2006, Breast Cancer Research.

Non-contrast enhanced MRI for evaluation of breast lesions: comparison of non-contrast enhanced high spectral and spatial resolution (HiSS) images versus contrast enhanced fat-suppressed images.

Hiroyuki Abe, Xiaobing Fan, Lorenzo L. Pesce, 2011, Academic radiology.

Fat suppression with spectrally selective inversion vs. high spectral and spatial resolution MRI of breast lesions: Qualitative and quantitative comparisons

Hiroyuki Abe, Xiaobing Fan, Gregory S Karczmar, 2006, Journal of magnetic resonance imaging : JMRI.

Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.

Nandita Mitra, Georgia Chenevix-Trench, Susan L Neuhausen, 2009, Cancer research.

A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.

Harvey Risch, Yian A Chen, Mads Thomassen, 2018, Cancer research.

Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

Zhimin Huo, Maryellen L Giger, Charles E Metz, 2002, Radiology.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.

Gordon B Mills, Shelly Cummings, Laura Esserman, 2002, Journal of the National Cancer Institute.

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

Ellen Warner, Ping Sun, Olufunmilayo I Olopade, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYC in breast tumor progression

Olufunmilayo I Olopade, O. Olopade, Yinghua Chen, 2008, Expert review of anticancer therapy.

The Breast–Thyroid Cancer Link: A Systematic Review and Meta-analysis

Peter Angelos, Olufunmilayo I Olopade, E. Kaplan, 2016, Cancer Epidemiology, Biomarkers & Prevention.

Relationships between computer-extracted mammographic texture pattern features and BRCA1/2mutation status: a cross-sectional study

Hui Li, Li Lan, Claudia Giambartolomei, 2014, Breast Cancer Research.

Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.

Hiroyuki Abe, Olufunmilayo I Olopade, Gillian M Newstead, 2013, AJR. American journal of roentgenology.

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Nola Hylton, Carolyn Mies, Olufunmilayo I Olopade, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.

Dezheng Huo, Olufunmilayo I Olopade, James J Dignam, 2013, Journal of the National Cancer Institute.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2002, The New England journal of medicine.

The effect of varying spectral resolution on the quality of high spectral and spatial resolution magnetic resonance images of the breast

Gillian Newstead, Xiaobing Fan, Gregory S Karczmar, 2003, Journal of magnetic resonance imaging : JMRI.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.

Colin C Pritchard, Stephen J Salipante, Gail P Jarvik, 2012, The Journal of molecular diagnostics : JMD.

Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.

Michael D Feldman, Olufunmilayo I Olopade, O. Olopade, 2002, Cancer research.

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers

Daniel L Gillen, Susan L Neuhausen, Fergus Couch, 2009, Breast Cancer Research.

A compact VEGF signature associated with distant metastases and poor outcomes

Zhiyuan Hu, Charles M Perou, Olufunmilayo I Olopade, 2009, BMC medicine.

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

Zhiyuan Hu, Charles M Perou, Jason I. Herschkowitz, 2007, Genome Biology.

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Susan L Neuhausen, Olufunmilayo I Olopade, Judy E Garber, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYC and Breast Cancer.

Olufunmilayo I Olopade, O. Olopade, Jinhua Xu, 2010, Genes & cancer.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Anne M Wallace, Michael Hogarth, Lajos Pusztai, 2016, The New England journal of medicine.

Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment.

Li Lan, Hui Li, Maryellen L Giger, 2007, Academic radiology.

Direct-to-consumer marketing of genetic tests for cancer: buyer beware.

Olufunmilayo I Olopade, O. Olopade, Stacy Gray, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

Zhiyuan Hu, Charles M Perou, Andrew F Olshan, 2018, Journal of the National Cancer Institute.

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

Charis Eng, Fergus Couch, Kevin Sweet, 2013, British Journal of Cancer.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

Charles M Perou, Dezheng Huo, Olufunmilayo I Olopade, 2013, Nature Communications.

Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.

Jing Zhang, Dezheng Huo, Olufunmilayo I Olopade, 2013, Carcinogenesis.

Genetic Determinants of Breast Cancer Risk: A Review of Current Literature and Issues Pertaining to Clinical Application

Olufunmilayo I Olopade, O. Olopade, U. O. Njiaju, 2012, The breast journal.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Rosalind Eeles, Susan L Neuhausen, Fergus J Couch, 2010, JAMA.

High spectral and spatial resolution MRI of breast lesions: preliminary clinical experience.

Hiroyuki Abe, Gregory S Karczmar, Milica Medved, 2006, AJR. American journal of roentgenology.

BRCA2 T2722R is a deleterious allele that causes exon skipping.

Olufunmilayo I Olopade, Adrian R Krainer, A. Krainer, 2002, American journal of human genetics.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Anne Wallace, Emanuel F Petricoin, Rita Nanda, 2015, Clinical Cancer Research.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.